| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |